Details of the Drug

General Information of Drug (ID: DMINFHS)

Drug Name

DPX Survivac

Indication

Disease Entry	ICD 11	Status	REF
Diffuse large B-cell lymphoma	2A81	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02323230) A Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCL. U.S. National Institutes of Health.